Diagnostics

Chembio Diagnostics Inc (NASDAQ: CEMI) has launched the commercial distribution of an FDA-Emergency Use Authorized rapid point-of-care COVID-19 antigen test.  Product inventory is on-hand and immediately available for shipment to Chembio customers across the U.S. The SCoV-2 Ag...

CVS Health Corp (NYSE: CVS) is capping purchases of rapid, over-the-counter COVID-19 tests, with a maximum of six packages available online and four in its pharmacies. The limits apply to Abbott Laboratories' (NYSE: ABT) BinaxNOW along with a test from Ellume, according to an...

The FDA has granted pre-market approval to Thermo Fisher Scientific Inc's (NYSE: TMO) Oncomine Dx Target Test. The approval for the test comes as a companion diagnostic to identify patients with isocitrate dehydrogenase-1 (IDH1) mutated cholangiocarcinoma (CCA) who may be...

The FDA has issued an Emergency Use Authorization (EUA) for Becton Dickinson and Co's (NYSE: BDX) BD Veritor At-Home COVID-19 Test. Also Read: BD's Automated Molecular Diagnostics Platform Wins FDA Approval, Initial Test For HPV The at-home COVID-19 rapid antigen...

Becton Dickinson and Co (NYSE: BDX) has received FDA approval for its automated, sample-to-answer, high-throughput BD Cor system along with the BD Onclarity HPV Assay for extended genotyping of human papillomavirus (HPV). The modular and scalable BD Cor includes an automated sample...

Fall in demand for COVID-19 screening has led LumiraDx to slash $2 billion off the value of a planned reverse merger with a special purpose acquisition company (SPAC). See: LumiraDx Withdraws $100M IPO In Favor Of $5B SPAC Merger.  First announced in April, the U.K.-based...

Biocept Inc (NASDAQ: BIOC) has announced new data from a study assessing its cerebrospinal fluid assay, CNSide. Data showed that CNSide detected tumor cells and identified actionable mutations in lung cancer patients with leptomeningeal carcinomatosis. The study will be presented at the...

Co-Diagnostics Inc's (NASDAQ: CODX) Q2 revenue increased 14% Y/Y to $27.4 million, primarily due to Logix Smart COVID-19 Test sales, beating the consensus of $20.77 million. Gross profit increased 37.6% to $24.9 million, with margin expanding to 90.8% from 75.1% in Q2 FY20 due to...

Diesel Laptops Tyler Robertson is bringing diagnostics on-demand to fleets and disrupting the repair economy Image by David ROUMANET from Pixabay

Laboratory Corp. of America Holdings (NYSE: LH) and Quest Diagnostics Inc (NYSE: DGX) could benefit from a "significant wave" of consolidation in the lab testing and diagnostics sector, according to KeyBanc Capital Markets.  The Analyst Analyst Donald Hooker upgraded Laboratory...

The 35-percent sell-off in shares of EXACT Sciences Corporation (NASDAQ: EXAS) offer an attractive entry point, according to BTIG Research.  The molecular diagnostics product company's main product is Cologuard, which is used to detect colorectal cancer. The Analyst Analyst Sean...

Foundation Medicine Inc (NASDAQ: FMI), a manufacturer of genomic analysis diagnostics for solid and circulating cancer, is  uniquely positioned in comprehensive cancer profiling, a Cowen analyst said.  The Analyst Cowen analyst Doug Schenkel initiated coverage of Foundation Medicine...

Small market caps, attractive growth prospects and idiosyncratic product cycles among diagnostics companies can lead to valuation volatility while also creating attractive M&A opportunities. The Analyst Goldman Sachs analyst Patrick Donnelly initiated coverage on the diagnostics sector with a...

Business textbooks looking to include a chapter on a deal gone bad should take a closer look at Walgreens Boots Alliance Inc (NASDAQ: WBA)'s partnership with Theranos Inc. Theranos is a startup company whose testing devices called Edison examine blood samples to identify dozens of conditions. What...